cytisine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Li, XN; Liu, R; Peng, T; Sun, X; Yang, K; Zhang, T | 1 |
1 other study(ies) available for cytisine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Tonkinensine B induces apoptosis through mitochondrial dysfunction and inactivation of the PI3K/AKT pathway in triple-negative breast cancer cells.
Topics: Adenosine Triphosphate; Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Azocines; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Humans; Membrane Potential, Mitochondrial; Mitochondria; Phosphatidylinositol 3-Kinases; Phosphorylation; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pterocarpans; Quinolizines; Signal Transduction; Sophora; Triple Negative Breast Neoplasms | 2021 |